Muhammed H. Rahaman
0000-0002-5454-8958
Publication & Citation Trends
Publications
0 total
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Cited by 4
Semantic Scholar
A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer
Cited by 2
Semantic Scholar
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer OA
Cited by 1
Semantic Scholar
Abstract 5701: AU2-94: A CDK4-specific inhibitor with the marked anti-tumor efficacy
Cited by 0
Semantic Scholar
CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer OA
Cited by 6
Semantic Scholar
Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition OA
Cited by 6
Semantic Scholar
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Cited by 14
Semantic Scholar
CDK12: a potential therapeutic target in cancer.
Cited by 27
Semantic Scholar
Research Topics
Cancer-related Molecular Pathways
(9)
Protein Degradation and Inhibitors
(8)
Advanced Breast Cancer Therapies
(5)
Prostate Cancer Treatment and Research
(3)
Ubiquitin and proteasome pathways
(3)
Affiliations
South Australia Pathology
University of South Australia
Mawlana Bhashani Science and Technology University
Centre for Cancer Biology
Directorate General of Health Services